Vetter And Sentry Biopharma Services Establish Preferred Partnership Agreement

Vetter and Sentry BioPharma Services have signed a preferred partnership agreement. Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The collaboration will help streamline the path of study drugs from filling lab to clinic while safeguarding product integrity.

The Chicago facility, which focuses on preclinical to phase II projects, is the former’s first outside of Germany and is an expansion of Vetter Development Service. It will be operational at the beginning of Q4 2010.